JOSÉ MANUEL VAGACE VALERO
PROFESOR TITULAR UNIVERSIDAD INTERINO (T. C. 6 HORAS LECTIVAS/6 HORAS TUTORÍAS)
Departamento de CIENCIAS BIOMÉDICAS
FACULTAD DE MEDICINA Y CIENCIAS DE LA SALUD
- Scopus: 16318174400
- Dialnet: 637110
- Índice H: 12
Grupo de investigación
Farmacogenética clínica
Instituto de investigación
Instituto Universitario de Biomarcadores de Patologías Moleculares
Asignaturas
Consulta toda la información investigadora de JOSÉ MANUEL VAGACE VALERO en el Portal de Investigación.
Publicaciones:
- 2023: Adolescent cancer care: What has changed in Spain in the past decade?
- 2023: Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet)
- 2022: A new case of acquired haemophilia B in the context of liver autoimmune disease
- 2022: Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL-SEHOP-PETHEMA-2013
- 2021: Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment
- 2021: Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia
- 2020: C>A substitution in NT 46 of the 3' UTR region (the α complex protected region) of the alpha-1 globin gene: A non-deletional mutation or polymorphism?
- 2020: Management of iron deficiency in various clinical conditions and the role of intravenous iron: Recommendations of the Spanish Erythropathology Group of the Spanish Society of Haematology and Haemotherapy
- 2020: Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies
- 2020: Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia